<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04222166</url>
  </required_header>
  <id_info>
    <org_study_id>19-003</org_study_id>
    <nct_id>NCT04222166</nct_id>
  </id_info>
  <brief_title>Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications</brief_title>
  <official_title>Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MED Institute Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MED Institute Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry will assess clinical outcomes following the use of Cryopreserved Amniotic&#xD;
      Membrane (CAM) for the treatment of orthopedic and various other conditions. This registry&#xD;
      will collect outcomes data via a registry of up to 100 patients who have received treatment&#xD;
      with CAM in the post-market setting. Patients will be enrolled from up to five healthcare&#xD;
      centers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this registry is to collect outcomes data via a registry on the uses of CAM&#xD;
      in the post-market setting, including:&#xD;
&#xD;
        -  Adverse events related to the treatment, or the product, will be collected for up to 12&#xD;
           weeks following the treatment.&#xD;
&#xD;
        -  Improvements in appropriate effectiveness markers for CAM use in patients treated for&#xD;
           various conditions.&#xD;
&#xD;
        -  Improvements in overall quality of life resulting from CAM treatment in patients.&#xD;
&#xD;
      An additional objective is to determine standard of care follow-up for the target treatments,&#xD;
      including effectiveness metrics used and typical follow-up schedule.&#xD;
&#xD;
      This registry is intended to collect clinical data from patients for analysis purposes only&#xD;
      and will not be used to treat patients. The plan does not allow for any deviation from&#xD;
      standard of care practice. Therefore, there is no added risk to patients from participating&#xD;
      in the registry.&#xD;
&#xD;
      The sponsor will use an electronic data capture (EDC) system for capturing all the data from&#xD;
      the sites. The system will be built and validated prior to initiation of the sites. Each&#xD;
      participating physician or appropriately trained designee shall enter data into the EDC&#xD;
      system, providing all applicable data and documentation to the sponsor. Data will be reviewed&#xD;
      for missing data, data consistency, and reasonableness of responses. Discrepancies will be&#xD;
      resolved through a formal query process within the EDC system, and may involve direct contact&#xD;
      with hospital staff.&#xD;
&#xD;
      The conduct of the registry will be supervised through a process of centralized and on-site&#xD;
      monitoring. The sponsor may remotely monitor the registry for data completeness and for&#xD;
      adverse events. On-site monitoring will be implemented as necessary throughout the course of&#xD;
      the registry. The physician/clinic will provide direct access to source data/documents for&#xD;
      registry-related monitoring, audits and IRB review.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 16, 2019</start_date>
  <completion_date type="Actual">August 6, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>12 Weeks</target_duration>
  <primary_outcome>
    <measure>Incidence of related serious adverse events</measure>
    <time_frame>12 weeks</time_frame>
    <description>Number of related serious adverse events occurred</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in pain score (0-10; higher scores mean worse outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in analgesic use</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in analgesic use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in wound size</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in wound size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to complete wound closure</measure>
    <time_frame>12 weeks</time_frame>
    <description>Time to complete wound closure</description>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Orthopedic Disorder</condition>
  <condition>Wound</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CAM</intervention_name>
    <description>Cryopreserved Amniotic Membrane</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A patient is suitable for inclusion in this registry if the patient has been treated with&#xD;
        CAM for any indication as per the standard of care practice.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        • A patient is suitable for inclusion in this registry if the patient has been treated with&#xD;
        CAM for any indication as per the standard of care practice.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        • Patients are excluded from registry enrollment if they are under the age of 22 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore Heise, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>MED Institute Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Regenerative Medicine and Pain Management Physicians</name>
      <address>
        <city>Gulf Breeze</city>
        <state>Florida</state>
        <zip>32563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foot and Ankle Specialists of South Jersey</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 3, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

